Ignite Creation Date:
2024-05-05 @ 4:38 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00282763
Status:
TERMINATED
Last Update Posted:
2015-11-23
First Post:
2006-01-24
Brief Title:
A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia Also Known as PHN or Post Shingles Pain 0686-005
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
Proprietary Information - Exploratory Non-confirmatory Trial
Status:
TERMINATED
Status Verified Date:
2015-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this Study is to test the Safety and Effectiveness of MK0686 in relieving neuropathic chronic pain as experienced by patients with Postherpetic Neuralgia Also Know as PHN or Post Shingles Pain
This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time Full information is available to trial participants
This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time Full information is available to trial participants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005_090 | None | None | None |